Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Oops! Arena’s CEO Neglects to Mention Diet Drug Causes Cancer in Rats
BNET Pharma
Monday, January 31, 2011 - 6:51pm
tags:
cancer, obesity, Arena Pharmaceuticals, Lorqess, Jack Lief
Drug Approved! Now Who's Going to Launch It?
Motley Fool
Monday, January 31, 2011 - 6:50pm
tags:
Depomed, shingles, postherpetic neuralgia, Gralise, Merck, Abbott Laboratories, GSK, Pfizer
Earnings Preview: Pfizer
Seeking Alpha
Monday, January 31, 2011 - 5:08pm
tags:
earnings, Pfizer
A Foursome Of Pharma Earnings Suggests Business Is Still Tough
Investopedia
Monday, January 31, 2011 - 5:07pm
tags:
earnings, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, MannKind, Novartis, Vivus
Is Johnson & Johnson the Perfect Stock?
Motley Fool
Monday, January 31, 2011 - 5:06pm
tags:
JNJ
Sanofi, Genzyme Agree on Merger Outline
TheStreet.com
Monday, January 31, 2011 - 4:49pm
tags:
M&A, Genzyme, Sanofi
Novartis Says FDA Approves Menveo in Kids, Not Infants
Bloomberg
Monday, January 31, 2011 - 11:56am
tags:
FDA, Novartis, vaccines, Menveo, meningococcal disease
What Gralise Approval Means for Depomed
Seeking Alpha
Monday, January 31, 2011 - 11:54am
tags:
Depomed, Gralise, gabapentin, postherpetic neuralgia
Orexigen shares jump ahead of FDA decision
Marketwatch
Monday, January 31, 2011 - 11:53am
tags:
FDA, Contrave, Orexigen
Actelion Enters Evel Knievel Territory
WSJ Online
Monday, January 31, 2011 - 11:51am
tags:
Actelion, Tracleer, PAH
Pfizer Completes Tender Offer For Shares Of King Pharmaceuticals, Inc.
Yahoo
Monday, January 31, 2011 - 11:49am
tags:
Pfizer, M&A, King, tender offer
Allergan and MAP Pharmaceuticals Announce Collaboration on LEVADEX(TM) Investigational Therapy for Acute Migraine
Trading Markets
Monday, January 31, 2011 - 8:39am
tags:
Allergan, MAP Pharmaceuticals, Levadex, migraines
Which Pharma Product Websites are Driving Consumers to the Doctor to Request Prescriptions?
Centre Daily Times, PA
Monday, January 31, 2011 - 8:24am
tags:
direct to consumer marketing
Aurobindo gets USFDA nod for anti-herpes tablets
Business Standard, India
Monday, January 31, 2011 - 8:17am
tags:
Aurobindo, Famciclovir
Courts Clear Way for Consumers to Sue Drug Companies
FairWarning
Monday, January 31, 2011 - 8:16am
tags:
lawsuits
Daiichi Sankyo Profit Grows 34%
WSJ
Monday, January 31, 2011 - 8:13am
tags:
Daiichi Sankyo, earnings
Dr. Reddy’s Provides Update on the Fexofenadine-Pseudoephedrine 24 Hour Litigation
Genetic Engineering News
Monday, January 31, 2011 - 8:12am
tags:
Dr Reddy's, Allegra, Sanofi
Mylan Pharma Nisoldipine ER tablets gets FDA approval
Pharmaceutical Business Review
Monday, January 31, 2011 - 8:10am
tags:
Mylan, Sular, Nisoldipine, Shionogi
Generics Companies Weigh In on Biological Drugs
WSJ
Monday, January 31, 2011 - 8:00am
tags:
biosimilars
Mylan's Matrix Obtains License for Promising HIV/AIDS Treatment
PR-USA.net
Monday, January 31, 2011 - 7:57am
tags:
Mylan, Matrixx, HIV, antiretrovirals, Tibotec, TMC278

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.